Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Carotech Announces New Study Linking Tocomin® to Protection Against Stroke-Induced Neurodegeneration
NIH-funded study conducted at the Ohio State University Medical Center, published in the October issue of the American Heart Association’s journal STROKE, indicates that rats supplemented with Tocomin® showed more protection against stroke-induced injury compared to unsupplemented controls.
- Carotech Announces New Study Linking Tocomin® to Protection Against Stroke-Induced Neurodegeneration
NIH-funded study conducted at the Ohio State University Medical Center, published in the October issue of the American Heart Association’s journal STROKE, indicates that rats supplemented with Tocomin® showed more protection against stroke-induced injury compared to unsupplemented controls.
- Carotech Announces New Study Linking Tocomin® to Protection Against Stroke-Induced Neurodegeneration
NIH-funded study conducted at the Ohio State University Medical Center, published in the October issue of the American Heart Association’s journal STROKE, indicates that rats supplemented with Tocomin® showed more protection against stroke-induced injury compared to unsupplemented controls.
- Carotech Announces New Study Linking Tocomin® to Protection Against Stroke-Induced Neurodegeneration
NIH-funded study conducted at the Ohio State University Medical Center, published in the October issue of the American Heart Association’s journal STROKE, indicates that rats supplemented with Tocomin® showed more protection against stroke-induced injury compared to unsupplemented controls.
- Carotech Announces New Study Linking Tocomin® to Protection Against Stroke-Induced Neurodegeneration
NIH-funded study conducted at the Ohio State University Medical Center, published in the October issue of the American Heart Association’s journal STROKE, indicates that rats supplemented with Tocomin® showed more protection against stroke-induced injury compared to unsupplemented controls.
- Carotech Announces New Study Linking Tocomin® to Protection Against Stroke-Induced Neurodegeneration
NIH-funded study conducted at the Ohio State University Medical Center, published in the October issue of the American Heart Association’s journal STROKE, indicates that rats supplemented with Tocomin® showed more protection against stroke-induced injury compared to unsupplemented controls.
- Mouse Study Indicates That Combination of Lycopene and Vitamin E Inhibits Growth of Prostate Tumors
May issue of the Journal of Nutrition features mouse study which showed that the combination of lycopene and vitamin E suppresses tumor growth in mice by 73 percent and increases survival time by 40 percent. Study also indicated that lycopene alone tends to inhibit tumor growth and to prolong survival time as well, but less effectively (53 percent and 19 percent, respectively).
- Mouse Study Indicates That Combination of Lycopene and Vitamin E Inhibits Growth of Prostate Tumors
May issue of the Journal of Nutrition features mouse study which showed that the combination of lycopene and vitamin E suppresses tumor growth in mice by 73 percent and increases survival time by 40 percent. Study also indicated that lycopene alone tends to inhibit tumor growth and to prolong survival time as well, but less effectively (53 percent and 19 percent, respectively).
- Mouse Study Indicates That Combination of Lycopene and Vitamin E Inhibits Growth of Prostate Tumors
May issue of the Journal of Nutrition features mouse study which showed that the combination of lycopene and vitamin E suppresses tumor growth in mice by 73 percent and increases survival time by 40 percent. Study also indicated that lycopene alone tends to inhibit tumor growth and to prolong survival time as well, but less effectively (53 percent and 19 percent, respectively).
- Association Applauds “Well Done” Vitamin E Study
The study, "The relationship between dose of vitamin E and suppression of oxidative stress in humans," reported that a dose of 3,200 International Units of vitamin E is needed to reduce oxidative stress in individuals at risk for cardiovascular disease, compared with how previous trials using lower doses failed to show any benefits for the vitamin. Fabricant called the study a “very well done multiple ascending dose study."
- Association Applauds “Well Done” Vitamin E Study
The study, "The relationship between dose of vitamin E and suppression of oxidative stress in humans," reported that a dose of 3,200 International Units of vitamin E is needed to reduce oxidative stress in individuals at risk for cardiovascular disease, compared with how previous trials using lower doses failed to show any benefits for the vitamin. Fabricant called the study a “very well done multiple ascending dose study."
- Association Applauds “Well Done” Vitamin E Study
The study, "The relationship between dose of vitamin E and suppression of oxidative stress in humans," reported that a dose of 3,200 International Units of vitamin E is needed to reduce oxidative stress in individuals at risk for cardiovascular disease, compared with how previous trials using lower doses failed to show any benefits for the vitamin. Fabricant called the study a “very well done multiple ascending dose study."
- Natural Products Association Responds to JAMA Report on Vitamin E, C Study and Cardiovascular Disease
The Natural Products Association has issued a statement in response to new findings published Tuesday, November 11, in The Journal of the American Medical Association (JAMA) on whether long-term vitamin E or vitamin C supplementation decreases the risk of major cardiovascular events among men.
- Natural Products Association Responds to JAMA Report on Vitamin E, C Study and Cardiovascular Disease
The Natural Products Association has issued a statement in response to new findings published Tuesday, November 11, in The Journal of the American Medical Association (JAMA) on whether long-term vitamin E or vitamin C supplementation decreases the risk of major cardiovascular events among men.
- Natural Products Association Responds to JAMA Report on Vitamin E, C Study and Cardiovascular Disease
The Natural Products Association has issued a statement in response to new findings published Tuesday, November 11, in The Journal of the American Medical Association (JAMA) on whether long-term vitamin E or vitamin C supplementation decreases the risk of major cardiovascular events among men.
- Natural Products Association Responds to JAMA Report on Vitamin E, C Study and Cardiovascular Disease
The Natural Products Association has issued a statement in response to new findings published Tuesday, November 11, in The Journal of the American Medical Association (JAMA) on whether long-term vitamin E or vitamin C supplementation decreases the risk of major cardiovascular events among men.
- Natural Products Association Responds to JAMA Report on Vitamin E, C Study and Cardiovascular Disease
The Natural Products Association has issued a statement in response to new findings published Tuesday, November 11, in The Journal of the American Medical Association (JAMA) on whether long-term vitamin E or vitamin C supplementation decreases the risk of major cardiovascular events among men.
- Natural Products Association Responds to JAMA Report on Vitamin E, C Study and Cardiovascular Disease
The Natural Products Association has issued a statement in response to new findings published Tuesday, November 11, in The Journal of the American Medical Association (JAMA) on whether long-term vitamin E or vitamin C supplementation decreases the risk of major cardiovascular events among men.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Children whose mothers had a low intake of vitamin E during pregnancy are more likely to develop wheezing and asthma by age five.
This research appears in the first issue for September 2006 of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society.
Graham Devereux, M.D., Ph.D., of the Department of Environmental and Occupational Medicine at the University of Aberdeen in the United Kingdom, and seven associates assessed maternal nutrient and respiratory status in 1,253 mothers and children during a five-year period.
According to the authors, children born to mothers from the lowest quintile of vitamin E intake were over five times more likely to manifest early persistent asthma than children whose mothers were in the highest quintile.
"Our findings suggest that vitamin E has a dual effect on lung function and airway inflammation and that the effects could change at differing periods of prenatal and early life," said Dr. Devereux. "Lung function was associated with early vitamin E exposure independent of atopy, whereas allergic airway inflammation was associated with vitamin E exposure in later pregnancy."
However, the researchers also noted that the airways are fully developed by 16 weeks after conception and, consequently, vitamin E exposure in early pregnancy may be more likely to influence airway function than exposure later in pregnancy.
"The present study suggests that children's own nutrient intake at the age of five does not modify the associations between maternal nutrient intake and respiratory outcomes in the children," said Dr. Devereux.
The study cited vegetable oils (sunflower, rapeseed and corn), margarine, wheat germ, nuts and sunflower seeds as major food sources of vitamin E for mothers in the U.K.
In a prior report on this group of children, the researchers found that two-year-olds whose mothers' vitamin E intake during pregnancy had been relatively low were more likely to wheeze even when they had no cold.
For the previous study, the investigators recruited 2,000 pregnant women at 12 months gestation who were attending area antenatal clinics between 1997 and 1999. Plasma antioxidant concentrations were measured in 1,856 mothers at 12 weeks gestation. In addition, symptom questionnaire data was later obtained for 1,253 children. From that group, 478 children were able to provide a lung function test measurement.
In light of the new findings, the authors concluded that the relationship shown between mothers' vitamin E intake during pregnancy and the respiratory outcomes of their children were likely "underestimates of the true association."
"The results of the present study suggest that dietary modification or supplementation during pregnancy to reduce the likelihood of childhood asthma warrants further investigation," said Dr. Devereux.
The researchers added that vitamin E supplementation in adults with established asthma has not been shown to be of clinical benefit.
###
|